Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations

Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high. The post Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations appeared first on BeInCrypto.